Document is current
Any future updates will be listed below
-
Authors
Mulder, Bart A https://orcid.org/0000-0002-4411-3918
Khalilian Ekrami, Neda https://orcid.org/0000-0003-3646-3106
Van De Lande, Martijn E https://orcid.org/0000-0002-6003-5999
Nguyen, Bao-Oanh https://orcid.org/0000-0002-6043-4172
Weberndorfer, Vanessa
Crijns, Harry J
Geelhoed, Bastiaan
Blaauw, Yuri
Hemels, Martin EW
Tieleman, Robert G https://orcid.org/0000-0002-7654-2098
Scheerder, Coert OS
De Melis, Mirko
Schotten, Ulrich
Linz, Dominik
Van Gelder, Isabelle C
Rienstra, Michiel https://orcid.org/0000-0002-2581-070X
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02726698 at ClinicalTrials.govDocuments that mention this clinical trial
Association between circulating biomarkers and atrial fibrillation burden in patients with paroxysmal atrial fibrillation: a subanalysis of the RACE V study
https://doi.org/10.1136/openhrt-2025-003433
Mechanisms of atrial fibrillation
https://doi.org/10.1136/heartjnl-2018-314267
Women have less progression of paroxysmal atrial fibrillation: data from the RACE V study
https://doi.org/10.1136/openhrt-2023-002534
Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillation
https://doi.org/10.1136/heartjnl-2022-321027
High heart rates during paroxysmal atrial fibrillation: continuous rhythm monitoring data of the RACE V study
https://doi.org/10.1136/heartjnl-2024-324376
Healthcare utilisation and quality of life according to atrial fibrillation burden, episode frequency and duration
https://doi.org/10.1136/heartjnl-2024-324016
Brady- and tachyarrhythmias detected by continuous rhythm monitoring in paroxysmal atrial fibrillation
https://doi.org/10.1136/heartjnl-2022-322253
-
Funding
Funding for this research was provided by:
Heart Foundation (CVON 2014-9)
Medtronic Trading
- License Information
